HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression-Reference-Cited by-同舟云学术

HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression

Published:2014-04-30 Issue:11 Volume:135 Page:2579-2592
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vijaya Kumar Archana¹,Salem Gassar Ezeddin¹²,Spillmann Dorothe³,Stock Christian⁴,Sen Yin-Ping⁵,Zhang Ting⁵,Van Kuppevelt Toin H.⁶,Hülsewig Carolin¹,Koszlowski Eliene O.⁷,Pavao Mauro S.G.⁷,Ibrahim Sherif A.⁸,Poeter Michaela⁹,Rescher Ursula⁹,Kiesel Ludwig¹,Koduru Suresh¹⁰,Yip George W.⁵,Götte Martin¹

Affiliation:

1. Department of Gynecology and Obstetrics; Münster University Hospital; Münster Germany

2. Department of Physiology; Faculty of Medicine; Benghazi University; Libya

3. Department of Medical Biochemistry and Microbiology; The Biomedical Center, Uppsala University; Uppsala Sweden

4. Institute of Physiology II, University of Münster; Münster Germany

5. Department of Anatomy; Yong Loo Lin School of Medicine, National University of Singapore; Singapore

6. Department of Biochemistry; NCMLS; Radboud University Medical Centre; Nijmegen The Netherlands

7. Instituto de Bioquimica Medica, Universidade Federal do Rio de Janeiro; Brazil

8. Department of Zoology; Faculty of Science; Cairo University; Giza Egypt

9. Institute of Medical Biochemistry, ZMBE, University of Münster; Münster Germany

10. School of Medical Sciences, University of Hyderabad; Hyderabad India

Funder

Deutsche Forschungsgemeinschaft DFG IRTG “Molecular and Cellular GlycoSciences”

National Medical Research Council, Singapore

Deutscher Akademischer Austauschdienst DAAD Transformationspartnerschaften

DAAD PROBRAL Project

European Commission

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.28921/fullpdf

Reference50 articles.

1. Therapeutic value of glycosaminoglycans in cancer;Yip;Mol Cancer Ther,2006

2. Glycosaminoglycans: key players in cancer cell biology and treatment;Afratis;FEBS J,2012

3. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression;Nikolova;Carcinogenesis,2009

4. Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless;Baeg;Development,2001

5. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells;Delehedde;Exp Cell Res,1996

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Targeting of Heparan Sulfate 3-O- and 6-O-Sulfation in Breast Cancer Cells: Prospects for Attenuating Prothrombotic Tumor Cell Activities;ACS Pharmacology & Translational Science;2024-07-30

2. Advances in prognostic models for osteosarcoma risk;Heliyon;2024-04

3. Identification of drug responsible glycogene signature in liver carcinoma from meta-analysis using RNA-seq data;Glycoconjugate Journal;2024-04

4. Physiological and immune profiling of tilapia Oreochromis niloticus gills by high-throughput single-cell transcriptome sequencing;Fish & Shellfish Immunology;2023-10

5. Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA;Hepatology International;2023-05-23